Skip to content

VHL/CDO1 axis regulates chondrocyte ferroptosis and knee osteoarthritis progression.

Aug 2026 · Archives of Biochemistry and Biophysics · Vol 785, pp. 110980 · 0 citations · 27 references
Medicine

TL;DR

The findings reveal that the VHL/CDO1 axis regulates intracellular cysteine levels, mediates chondrocyte ferroptosis and OA progression, and may form a VHL/CDO1/cysteine negative feedback loop.

Abstract

Ferroptosis is closely associated with the pathogenesis of osteoarthritis (OA), though the underlying molecular mechanisms remain unclear. This study aims at exploring the role of CDO1 in chondrocyte ferroptosis. In this study, cell viability was assessed using the CCK8 assay. ROS levels were measured via flow cytometry. Lipid peroxidation was evaluated using the C11 BODIPY 581/591 fluorescent probe, and mitochondrial morphology was examined by transmission electron microscopy. Our results demonstrated that CDO1 was upregulated in cartilage tissues from patients with severe knee OA. IL-1β stimulation elevated ferroptosis levels in SW1353 cells, as indicated by reduced cell viability, extracellular matrix (ECM) accumulation and GSH levels, increased oxidative stress, lipid peroxidation and MDA content, and impaired mitochondrial morphology. These effects were reversed by the ferroptosis inhibitor Fer-1. Overexpression of CDO1 reduced intracellular cysteine levels and enhanced ferroptosis, whereas CDO1 knockdown produced the opposite effects. We further identified VHL as a binding partner of CDO1 and showed that VHL promoted CDO1 protein degradation. The ferroptosis and ECM degradation induced by CDO1 overexpression were rescued by VHL co-overexpression. Importantly, cysteine deficiency enhanced VHL activity, promoted CDO1-VHL interaction, and accelerated CDO1 degradation, thereby may form a VHL/CDO1/cysteine negative feedback loop. The function of CDO1/VHL axis was further validated in a rat OA model, where CDO1 exacerbated OA progression and VHL alleviated it. In summary, our findings reveal that the VHL/CDO1 axis regulates intracellular cysteine levels, mediates chondrocyte ferroptosis and OA progression.

View source

Similar papers

Sep 2026

Narirutin mitigates osteoarthritis by targeting USP15 to promote KEAP1 degradation and suppress chondrocyte ferroptosis.

BACKGROUND Osteoarthritis (OA) is a prevalent degenerative joint disease characterized by progressive cartilage degeneration and joint dysfunction, for which effective therapeutic options remain limited. Increasing evidence suggests that ferroptosis, an iron-dependent form of regulated cell death driven by lipid peroxi...

Xiang-Cheng Zhang, Su-Yu Ying, Yi-Ting Tu et al. · 0 citations
Open access Oct 2026

CWH43 Suppresses Ferroptosis-Associated Vulnerability Through Redox Adaptation in Colorectal Cancer

Ferroptosis is an iron-dependent form of regulated cell death that has emerged as a potential vulnerability in cancer cells under therapeutic stress. However, the mechanisms by which colorectal cancer cells modulate ferroptosis susceptibility remain incompletely understood. In this study, we investigated the role of CW...

Kuei-Yen Tsai, Po-Li Wei, Cheng-Chin Lee et al. · 0 citations
Open access Sep 2026

KIAA1429 promotes chondrocyte senescence and ferroptosis in osteoarthritis progression by facilitating m6A-mediated downregulation of USP3.

It is elucidated that KIAA1429 promotes the senescence and ferroptosis of chondrocytes by increasing m6A methylation of USP3 to suppress its stability, thereby contributing to the pathogenesis of OA.

Bin-Qing Ma, Jiang-Bo Zhao, Cheng Cheng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.